The system will be designed to treat post-amputation pain. The system will feature SPR’s proprietary method of percutaneously stimulating peripheral nerves. This involves the insertion of a very small medical wire or lead through the skin.
This NIH grant adds to a $2.8 million research grant from the U.S. Department of Defense for ongoing clinical trials that assess the safety and efficacy of SPR Therapeutics’ PNS therapy.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
